Wednesday, March 9, 2016
9:15 – 10:30am
Immuno-Oncology I: Attacking Cancer Antigens – Exploiting off-the-Shelf and Personalized Vaccines and Triggering of Immunogenic Cell Death
- Jeffrey M. Bockman, PhD, Vice President, Defined Health
- Robert Ang, MD, MBA, Chief Business Officer, Neon Therapeutics
- Ulrike Gnad-Vogt, MD, Chief Medical Officer, CureVac GmbH
- Stephen T. Isaacs, Chairman and Chief Executive Officer, Aduro BioTech, Inc.
- Taylor H. Schreiber MD, PhD, Chief Scientific Officer, Heat Biologics Inc.
- Mai-Britt Zocca, PhD, MSc, Chief Executive Officer, IO Biotech